FR2401916B1 - - Google Patents

Info

Publication number
FR2401916B1
FR2401916B1 FR7825487A FR7825487A FR2401916B1 FR 2401916 B1 FR2401916 B1 FR 2401916B1 FR 7825487 A FR7825487 A FR 7825487A FR 7825487 A FR7825487 A FR 7825487A FR 2401916 B1 FR2401916 B1 FR 2401916B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7825487A
Other versions
FR2401916A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10764177A external-priority patent/JPS5441874A/ja
Priority claimed from JP12499577A external-priority patent/JPS5459284A/ja
Priority claimed from JP12499277A external-priority patent/JPS5459273A/ja
Priority claimed from JP2890078A external-priority patent/JPS54122272A/ja
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of FR2401916A1 publication Critical patent/FR2401916A1/fr
Application granted granted Critical
Publication of FR2401916B1 publication Critical patent/FR2401916B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7825487A 1977-09-06 1978-09-05 Nouveaux derives de 5-hydroxy-1h-imidazole-4-carboxamide substitues en position 2, leur procede de production et composition pharmaceutique les contenant Granted FR2401916A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP10764177A JPS5441874A (en) 1977-09-06 1977-09-06 Novel 2-substituted imidazole derivative
JP12499577A JPS5459284A (en) 1977-10-17 1977-10-17 Novel 2-pyridylimidazole derivative
JP12499277A JPS5459273A (en) 1977-10-17 1977-10-17 Novel 2-arylimidazole derivative
JP2890078A JPS54122272A (en) 1978-03-13 1978-03-13 Novel 2-substituted phenylimidazole derivative

Publications (2)

Publication Number Publication Date
FR2401916A1 FR2401916A1 (fr) 1979-03-30
FR2401916B1 true FR2401916B1 (fr) 1982-07-02

Family

ID=27458967

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7825487A Granted FR2401916A1 (fr) 1977-09-06 1978-09-05 Nouveaux derives de 5-hydroxy-1h-imidazole-4-carboxamide substitues en position 2, leur procede de production et composition pharmaceutique les contenant

Country Status (14)

Country Link
US (1) US4218457A (fr)
AT (1) AT367412B (fr)
AU (1) AU507066B1 (fr)
BE (1) BE870236A (fr)
CA (1) CA1110623A (fr)
CH (1) CH636862A5 (fr)
DE (1) DE2838892A1 (fr)
DK (1) DK392578A (fr)
FR (1) FR2401916A1 (fr)
GB (1) GB2004544B (fr)
HU (1) HU184188B (fr)
IT (1) IT1160633B (fr)
NL (1) NL7809075A (fr)
SE (1) SE442865B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530916B2 (en) * 1979-08-08 1983-08-04 Sumitomo Chemical Company, Limited 4-carbamoyl imidazolium-5-olate derivatives
CA1151651A (fr) * 1979-08-08 1983-08-09 Takao Kiyohara Derives de 4-carbamoyl imidazolium-5-oleate, agents anti-tumeurs et immunosuppresseurs; compositions pharmaceutiques qui en renferment et preparation
US4464531A (en) * 1981-04-20 1984-08-07 Sumitomo Chemical Company, Limited 4-Carbamoylimidazolium-5-olate derivatives
US4503235A (en) * 1983-03-11 1985-03-05 Warner-Lambert Company Process for producing 4-carbamoyl-1H-imidazolium-5-olate
JPS60193997A (ja) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法
JP2009501721A (ja) * 2005-07-12 2009-01-22 アカディア ファーマシューティカルズ インコーポレイテッド レチノイン酸受容体における活性を伴う化合物
PE20080401A1 (es) 2006-07-07 2008-06-23 Boehringer Ingelheim Int DERIVADOS DE HETEROARIL-FENIL SUSTITUIDOS COMO INHIBIDORES DE B-Raf-QUINASAS
EP2149550A4 (fr) * 2007-04-27 2010-08-11 Takeda Pharmaceutical Composé hétérocyclique à cinq chaînons à teneur en azote
CL2008001943A1 (es) 2007-07-02 2009-09-11 Boehringer Ingelheim Int Compuestos derivados de fenil-triazol, inhibidores de enzimas de señales especificas que participan del control de la proliferacion celular; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer, infecciones, enfermedades inflamatorias y autoinmunes.
WO2009003998A2 (fr) * 2007-07-02 2009-01-08 Boehringer Ingelheim International Gmbh Nouveaux composés chimiques
AU2009295855A1 (en) 2008-09-29 2010-04-01 Boehringer Ingelheim International Gmbh Antiproliferative compounds
JP5871896B2 (ja) 2010-03-26 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｂ−ｒａｆキナーゼインヒビター
JP5871897B2 (ja) 2010-03-26 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ピリジルトリアゾール
JP5996532B2 (ja) 2010-07-15 2016-09-21 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 有害生物防除剤としての新規複素環式化合物
US8710055B2 (en) 2010-12-21 2014-04-29 Boehringer Ingelheim International Gmbh Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1360982A (en) * 1970-08-27 1974-07-24 Beecham Group Ltd Derivatives of 1-phenyl-5-aminoimidazole and compositions thereof
US3812136A (en) * 1972-05-05 1974-05-21 Merck & Co Inc Tri-substituted imidazoles
AU502122B2 (en) * 1976-07-02 1979-07-12 Sumitomo Chemical Company, Limited 5-0-acylated-imidazole-4-carboxamide derivatives
JPS604802B2 (ja) * 1976-09-07 1985-02-06 住友化学工業株式会社 制癌剤
US4140788A (en) * 1976-11-10 1979-02-20 Sumitomo Chemical Company, Limited N-Substituted imidazolecarboxamide derivatives

Also Published As

Publication number Publication date
AT367412B (de) 1982-07-12
DK392578A (da) 1979-03-07
SE7809373L (sv) 1979-03-07
US4218457A (en) 1980-08-19
IT7869049A0 (it) 1978-09-05
GB2004544B (en) 1982-09-15
NL7809075A (nl) 1979-03-08
HU184188B (en) 1984-07-30
CA1110623A (fr) 1981-10-13
DE2838892A1 (de) 1979-03-15
SE442865B (sv) 1986-02-03
CH636862A5 (de) 1983-06-30
FR2401916A1 (fr) 1979-03-30
BE870236A (fr) 1979-03-05
AU507066B1 (en) 1980-01-31
IT1160633B (it) 1987-03-11
ATA640778A (de) 1981-11-15
GB2004544A (en) 1979-04-04

Similar Documents

Publication Publication Date Title
DE2713321C2 (fr)
DE2740565C2 (fr)
DE2758333C2 (fr)
AU495917B2 (fr)
AU71461S (fr)
BG25819A1 (fr)
BG25855A1 (fr)
BE868323A (fr)
BG25823A1 (fr)
BE871419A (fr)
BE871991A (fr)
BE872973A (fr)
BE865722A (fr)
BG23438A1 (fr)
BE851449A (fr)
BG24331A1 (fr)
BG24713A1 (fr)
BG25808A1 (fr)
BG25809A1 (fr)
BG25810A1 (fr)
BG25811A1 (fr)
BG25812A1 (fr)
BG25825A1 (fr)
BG25815A1 (fr)
BG23462A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse